Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:1041-1051
Published online before print August 13, 2007, doi: 10.1161/CIRCULATIONAHA.106.645416
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Suppement
Right arrow All Versions of this Article:
116/9/1041    most recent
CIRCULATIONAHA.106.645416v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsui, A.
Right arrow Articles by Matsubara, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsui, A.
Right arrow Articles by Matsubara, H.
Related Collections
Right arrow Angiogenesis
Right arrow Cell signalling/signal transduction
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2007;116:1041-1051.)
© 2007 American Heart Association, Inc.


Vascular Medicine

Central Role of Calcium-Dependent Tyrosine Kinase PYK2 in Endothelial Nitric Oxide Synthase–Mediated Angiogenic Response and Vascular Function

Akihiro Matsui, MD; Mitsuhiko Okigaki, MD, PhD; Katsuya Amano, MD, PhD; Yasushi Adachi, MD, PhD; Denan Jin, MD, PhD; Shinji Takai, PhD; Tomoya Yamashita, MD, PhD; Seinosuke Kawashima, MD, PhD; Tatsuya Kurihara, PhD; Mizuo Miyazaki, MD, PhD; Kento Tateishi, MD, PhD; Shinsaku Matsunaga, MD; Asako Katsume, MD; Shoken Honshou, MD; Tomosaburo Takahashi, MD, PhD; Satoaki Matoba, MD, PhD; Tetsuro Kusaba, MD; Tetsuya Tatsumi, MD, PhD; Hiroaki Matsubara, MD, PhD

From the Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine, Kyoto (A.M., M.O., K.T., S.M., A.K., S.H., T. Takahashi, S.M., T. Kusaba, T. Tatsumi, H.M.); Departments of Internal Medicine II (K.A.) and Pathology I (Y.A.), Kansai Medical University, Osaka; Department of Pharmacology, Osaka Medical College, Takatsuki (D.J., S.T., M.M.); Division of Cardiovascular and Respiratory Medicine, Kobe University School of Medicine, Kobe (T.Y., S.K.); and Daiichi Asubio Pharma Co Ltd Biomedical Research Laboratories, Osaka (T. Kurihara), Japan.

Correspondence to Mitsuhiko Okigaki, MD, Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, 602–8566, Japan. E-mail okigakim{at}koto.kpu-m.ac.jp

Received August 9, 2005; accepted June 12, 2007.

Background— The involvement of Ca2+-dependent tyrosine kinase PYK2 in the Akt/endothelial NO synthase pathway remains to be determined.

Methods and Results— Blood flow recovery and neovessel formation after hind-limb ischemia were impaired in PYK2–/– mice with reduced mobilization of endothelial progenitors. Vascular endothelial growth factor (VEGF)–mediated cytoplasmic Ca2+ mobilization and Ca2+-independent Akt activation were markedly decreased in the PYK2-deficient aortic endothelial cells, whereas the Ca2+-independent AMP-activated protein kinase/protein kinase-A pathway that phosphorylates endothelial NO synthase was not impaired. Acetylcholine-mediated aortic vasorelaxation and cGMP production were significantly decreased. Vascular endothelial growth factor–dependent migration, tube formation, and actin cytoskeletal reorganization associated with Rac1 activation were inhibited in PYK2-deficient endothelial cells. PI3-kinase is associated with vascular endothelial growth factor–induced PYK2/Src complex, and inhibition of Src blocked Akt activation. The vascular endothelial growth factor–mediated Src association with PLC{gamma}1 and phosphorylation of 783Tyr-PLC{gamma}1 also were abolished by PYK2 deficiency.

Conclusion— These findings demonstrate that PYK2 is closely involved in receptor- or ischemia-activated signaling events via Src/PLC{gamma}1 and Src/PI3-kinase/Akt pathways, leading to endothelial NO synthase phosphorylation, and thus modulates endothelial NO synthase–mediated vasoactive function and angiogenic response.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
P. W. Sanders
Vascular consequences of dietary salt intake
Am J Physiol Renal Physiol, August 1, 2009; 297(2): F237 - F243.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W.-Z. Ying, K. Aaron, and P. W. Sanders
Dietary Salt Activates an Endothelial Proline-Rich Tyrosine Kinase 2/c-Src/Phosphatidylinositol 3-Kinase Complex to Promote Endothelial Nitric Oxide Synthase Phosphorylation
Hypertension, December 1, 2008; 52(6): 1134 - 1141.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. M. Weis, S.-T. Lim, K. M. Lutu-Fuga, L. A. Barnes, X. L. Chen, J. R. Gothert, T.-L. Shen, J.-L. Guan, D. D. Schlaepfer, and D. A. Cheresh
Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK
J. Cell Biol., April 3, 2008; 181(1): 43 - 50.
[Abstract] [Full Text] [PDF]